GC
INO icon

GMT Capital’s Inovio Pharmaceuticals INO Stock Holding History

GMT Capital’s Portfolio INO Stock Details INO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$219K Buy
+126,119
New +$208K 0.01% 71
2025
Q4 		– Sell
-126,119
Closed -$295K – 53
2025
Q3 		$295K Hold
126,119
– – 0.01% 64
2025
Q2 		$257K Hold
126,119
– – 0.01% 69
2025
Q1 		$206K Sell
126,119
-2
-0% -$4 0.01% 67
2024
Q4 		$231K Hold
126,121
– – 0.01% 55
2024
Q3 		$729K Buy
+126,121
New +$1.04M 0.03% 58
2023
Q4 		– Sell
-126,125
Closed -$589K – 72
2023
Q3 		$589K Hold
126,125
– – 0.02% 89
2023
Q2 		$676K Buy
+126,125
New +$1.02M 0.03% 78

Other funds holding INO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BCM
Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return